RecallDepth
Class II Terminated

Cathflo activase (ALTEPLASE), 2mg vials, Rx only, Genentech Inc., South San Francisco, CA 94080, NDC 50242-041-64

Company
Genentech, Inc.
Recall Initiated
May 20, 2024
Posted
June 5, 2024
Recall Number
D-0509-2024
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
Lot:3618858 = 105,759; Lot:3618873 =90,359
Firm Location
South San Francisco, CA, United States

Reason for Recall

Lack of Assurance of Sterility: Deformed stoppers observed during filling operations for Cathflo Activase.

Distribution

Nationwide within the United States

Lot / Code Info

Lot #: 3618858, 3618873, Exp. Date 01/31/2026

More recalls by Genentech, Inc.

View all recalls by this company →

Other recent Class II Drug recalls